Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 6, 1997, Pages 1140-1145

  Moore, Anna ^a   Weissleder, Ralph ^a   Bogdanov Jr , Alexei ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Dextran; Endocytosis; Iron oxide; Opsonization

Indexed keywords

COMPLEMENT COMPONENT C3; DEXTRAN; FIBRONECTIN; FLUORESCEIN ISOTHIOCYANATE; IODINE 125; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; PLASMA PROTEIN; VITRONECTIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; ENDOCYTOSIS; FLUORESCENCE MICROSCOPY; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IRON TRANSPORT; MACROPHAGE; MOUSE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; RAT; TUMOR CELL;

ANIMALS; CELLS, CULTURED; CONTRAST MEDIA; ENDOCYTOSIS; IRON; MACROPHAGES; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; OXIDES; SUSPENSIONS; TUMOR CELLS, CULTURED;

EID: 0031403932     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070629     Document Type: Article

References (32)

1. Shen T, Weissleder R, Papsiov M, Bogdanov A, Brady T. Monocrystalline iron oxide nanocompounds (MION): physiochemical properties. Magn Reson Med 1993; 29:599-604.
2. Harika L, Weissleder R, Poss K, Papisov M. Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies. Radiology 1996; 198:365-370.
3. Weissleder R, Bogdanov A, Papisov M. Drug targeting in magnetic resonance imaging. In: Torchilin V, ed. Handbook of targeted delivery of imaging agents. Boca Raton, FL: CRC Press Inc., 1995; 133-147.
4. Weissleder R, Bogdanov A, Papisov M. Drug targeting in MR imaging. Magn Reson Q 1992; 8:55-63.
5. Noske W, Lentzen H. Lange K, Keller K. Phagocytic activity of glial cells in culture. Exp Cell Res 1982; 142:437-445.
6. Neuwelt E. Weissleder R, Nilaver G. et al. Delivery of virussized iron oxide particles to rodent CNS neurons. Neurosurgery 1994; 34:777-784.
7. Zimmer C, Weissleder R, Poss K, Bogdanova A, Wright SC, Enochs WS. MR Imaging of phagocytosis in experimental glioma. Radiology 1995; 197:533-538.
8. Neuwelt E, Barnett P, Hellström K, Hellström I, McCormick C, Ramsey F. Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenografts. J Nucl Med 1994; 35:1831-1841.
9. Schulze E, Ferrucci J, Poss K, LaPointe L, Bogdanova A, Weissleder R. Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro. Invest Radiol 1995; 30:604-610.
10. Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032:89-118.
11. Weissleder R, Cheng H, Bogdanova A, Bogdanov A Jr. Magnetically labeled cells can be detected by MR imaging. J Magn Reson 1997; 7:258-263.
12. Wheeler K, Tel N, Williams M. Sheppard S, Levin V, Kabra P. Factors influencing the survival of rat brain tumor cells after in vitro treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 1975; 35:1464-1469.
13. Ovejera A, Houchens D. Human tumor xenografts in athymic nude mice as a preclinical screen for anticancer agents. Semin Oncol 1981; 8:386-393.
14. Bogdanova A. Nossiff N, Bogdanov A, Brady T, Weissleder R. The role of opsonins in cellular uptake of dextran stabilized superparamagnetic iron oxides. In: Proceedings of the 2nd annual meeting of the Society of Magnetic Resonance in Medicine. San Francisco: Society of Magnetic Resonance in Medicine 1994; 931.
15. Young P. An improved method for the detection of peroxidase-conjugated antibodies on immunoblots. J Virol Methods 1989; 24:227-235.
16. Goda Y, Pfeffer S. Identification of a novel N-ethylaleimide-sensitive cytosolic factor required for vesicular transport from endosomes to the trans-Golgi network in vitro. J Cell Biol 1991; 112:823-831.
17. Bogdanov A, Papisov M, Weissleder R, Shen T, Brady T. Opsonization of dextran stabilized iron oxides with plasma proteins. In: Proceedings of the 11th annual scientific meeting of the Society of Magnetic Resonance in Medicine. Berlin: Society of Magnetic Resonance in Medicine, 1992; 864.
18. Schwarzbaum S, Diamond, B. The J774.2 cell line presents antigen in a I region restricted manner. J Immunol 1983; 131: 674-677.
19. Zimmer C, Wright S, Engelhardt R, et al. Tumor cell endocytosis imaging facilitates delineation of glioma-brain interface. Exp Neurol 1997; 143:61-69.
20. Rabinovich M. Professional and non-professional phagocytes: an introduction. Trends Cell Biol 1995; 5:85-87.
21. Bjerknes R, Bjerkvig R, Laerum O. Phagocytic capacity of normal and malignant rat glial cells in culture. J Natl Cancer Inst 1987; 78:279-294.
22. Berlin R, Oliver J. Walter R. Surface functions during mitosis I: phagocytosis, pinocytosis and mobility of surface-bound Con A. Cell 1978; 15:327-341.
23. Quintart J, Leroy-Houyet MA, Trouet A, Baudhuin P. Endocytosis and chloroquine accumulation during the cell cycle of hepatoma cells in culture. J Cell Biol 1979; 82:644-653.
24. Pratten M, Lloyd J. Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochim Biophys Acta 1986; 881:307-313.
25. Berthiaume EP, Medina C, Swanson JA. Molecular size-fractionation during endocytosis in macrophages. J Cell Biol 1995; 129:989-998.
26. Diaz R, Mayorga LS, Weidman PJ, Rothman JE, Stahl PD. Vesicle fusion following receptor-mediated endocytosis requires a protein active in Golgi transport. Nature 1989; 339: 398-400.
27. Kodama T, Freeman M, Rohrer L, Zabrecky J. Matsudaira P, Krieger M. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature 1990; 343:531-535.
28. Shevach E. Macrophages and other accessory cells. In: Paul WE, ed. Fundamental immunology. New York: Raven Press, 1984; 72-75.
29. Takeshima H, Kuratsu J, Takeya M, Yoshimura T, Ushio Y. Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J Neurosurg 1994; 80:1056-1062.
30. Camp BJ, Dyhrman ST, Memoli VA, Mott LA, Barth RJ Jr. In situ cytokine production by breast cancer tumor-infiltrating lymphocytes. Ann Surg Oncol 1996; 3:176-184.
31. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med 1995; 36:1854-1861.
32. Weissleder R, Bogdanov A, Papisov M. Long-circulating iron oxides for MR imaging. Adv Drug Delivery Rev 1995; 16:321-334.